217 related articles for article (PubMed ID: 1566297)
1. Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol.
Antezana G; Zeballos R; Mendoza C; Lyevre P; Valda L; Cardenas F; Noriega I; Ugarte H; Dedet JP
Trans R Soc Trop Med Hyg; 1992; 86(1):31-3. PubMed ID: 1566297
[TBL] [Abstract][Full Text] [Related]
2. Combined antimonial allopurinol therapy in mucosal leishmaniasis.
Sampaio RN; Marchán EM; Vexenat A; Tristão RJ; Marsden PD
Mem Inst Oswaldo Cruz; 1990; 85(3):373-4. PubMed ID: 2134714
[No Abstract] [Full Text] [Related]
3. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
[No Abstract] [Full Text] [Related]
4. Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome.
Nonata R; Sampaio R; Marsden PD
Trans R Soc Trop Med Hyg; 1997; 91(1):77. PubMed ID: 9093636
[No Abstract] [Full Text] [Related]
5. [Miltefosine or meglumine antimoniate in leishmaniasis].
Joob B; Wiwanitkit V
Medicina (B Aires); 2015; 75(2):130-1. PubMed ID: 25919881
[No Abstract] [Full Text] [Related]
6. [Miltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis].
Garcia Bustos MF; Barrio A; Parodi C; Beckar J; Moreno S; Basombrio MA
Medicina (B Aires); 2014; 74(5):371-7. PubMed ID: 25347898
[TBL] [Abstract][Full Text] [Related]
7. Retention of antimony in hair during leishmaniasis treatment.
Dorea JG; Merchan-Hamann E; Ryan DE; Holzbecher J
Clin Chim Acta; 1989 Feb; 179(3):341-5. PubMed ID: 2714007
[No Abstract] [Full Text] [Related]
8. Effects of antimonial therapy for canine leishmaniasis on antibody titer.
Amusategui I; Sainz A; Tesouro MA
Ann N Y Acad Sci; 1998 Jun; 849():444-6. PubMed ID: 9668509
[No Abstract] [Full Text] [Related]
9. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
Kuyucu N; Kara C; Bakirtaç A; Teziç T
Pediatr Infect Dis J; 2001 Apr; 20(4):455-7. PubMed ID: 11332679
[TBL] [Abstract][Full Text] [Related]
10. Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV.
Laguna F; López-Vélez R; Soriano V; Montilla P; Alvar J; González-Lahoz JM
J Infect; 1994 May; 28(3):255-9. PubMed ID: 8089514
[TBL] [Abstract][Full Text] [Related]
11. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
Hueso M; Bover J; Serón D; Gil-Vernet S; Rufí G; Alsina J; Grinyó JM
Nephrol Dial Transplant; 1999 Dec; 14(12):2941-3. PubMed ID: 10570102
[No Abstract] [Full Text] [Related]
12. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
Amusategui I; Sainz A; Tesouro MA
Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
[No Abstract] [Full Text] [Related]
13. [A case of mucocutaneous leishmaniasis treated with success with a low dose of pentavalent antimonial].
Amato VS; de Oliveira LS; Silva AC; Machado FR; Amato JG; Nicodemo AC; Amato Neto V
Rev Soc Bras Med Trop; 1998; 31(2):221-4. PubMed ID: 9608241
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate.
Momeni AZ; Reiszadae MR; Aminjavaheri M
Int J Dermatol; 2002 Jul; 41(7):441-3. PubMed ID: 12121563
[TBL] [Abstract][Full Text] [Related]
15. [Renal function in patients with mucocutaneous leishmaniasis treated with pentavalent antimony compounds].
Veiga JP; Rosa TT; Kimachi T; Wolff ER; Sampaio RN; Gagliardi AR; Junqueira Júnior LF; Costa JM; Marsden PD
Rev Inst Med Trop Sao Paulo; 1985; 27(6):298-302. PubMed ID: 3014634
[No Abstract] [Full Text] [Related]
16. [Treatment of the mucosal form of leishmaniasis without response to glucantime, with liposomal amphotericin B].
Sampaio RN; Marsden PD
Rev Soc Bras Med Trop; 1997; 30(2):125-8. PubMed ID: 9148335
[TBL] [Abstract][Full Text] [Related]
17. Allopurinol in the treatment of American cutaneous leishmaniasis.
Martinez S; Marr JJ
N Engl J Med; 1992 Mar; 326(11):741-4. PubMed ID: 1738379
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
Esfandiarpour I; Dabiri SH
Int J Dermatol; 2007 Aug; 46(8):848-52. PubMed ID: 17651170
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of mucocutaneous leishmaniasis in littoral Bahia, Brazil.
Lago L; Vieira JB; Costa JL; Marsden PD
Trans R Soc Trop Med Hyg; 1990; 84(2):241. PubMed ID: 2389315
[No Abstract] [Full Text] [Related]
20. Treatment of recurrent cutaneous Leishmaniasis.
Momeni AZ; Aminjavaheri M
Int J Dermatol; 1995 Feb; 34(2):129-33. PubMed ID: 7737774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]